Found: 54
Select item for more details and to access through your institution.
Rituximab in myasthenia gravis: a “to be or not to be” inhibitor of T cell function.
- Published in:
- Annals of the New York Academy of Sciences, 2018, v. 1413, n. 1, p. 41, doi. 10.1111/nyas.13562
- By:
- Publication type:
- Article
Myasthenia gravis with antibodies to MuSK: an update.
- Published in:
- Annals of the New York Academy of Sciences, 2018, v. 1412, n. 1, p. 82, doi. 10.1111/nyas.13518
- By:
- Publication type:
- Article
Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 7, p. 4591, doi. 10.1007/s10072-022-06013-y
- By:
- Publication type:
- Article
In sickness and in health: when myasthenia gravis is a conjugal matter.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 5, p. 2099, doi. 10.1007/s10072-020-04944-y
- By:
- Publication type:
- Article
Benefit and danger from immunotherapy in myasthenia gravis.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 4, p. 1367, doi. 10.1007/s10072-021-05077-6
- By:
- Publication type:
- Article
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Italian recommendations for the diagnosis and treatment of myasthenia gravis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Italian recommendations for diagnosis and management of congenital myasthenic syndromes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Diagnostics of paraneoplastic neurological syndromes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Thymectomy in severe (Myasthenia Gravis Foundation of America classes IV–V) generalized myasthenia gravis: is the game really worth the candle? A retrospective analysis from a multi-institutional database.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2023, v. 63, n. 5, p. 1, doi. 10.1093/ejcts/ezad179
- By:
- Publication type:
- Article
Management challenges in muscle-specific tyrosine kinase myasthenia gravis.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1274, n. 1, p. 86, doi. 10.1111/j.1749-6632.2012.06781.x
- By:
- Publication type:
- Article
Response to Therapy in Myasthenia Gravis with Anti-MuSK Antibodies.
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1132, p. 76, doi. 10.1196/annals.1405.012
- By:
- Publication type:
- Article
Editorial: News and Views in the Management of Myasthenia Gravis.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.769086
- By:
- Publication type:
- Article
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135378
- By:
- Publication type:
- Article
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts.
- Published in:
- Muscle & Nerve, 2011, v. 44, n. 1, p. 36, doi. 10.1002/mus.22006
- By:
- Publication type:
- Article
Determinants of cognitive impairment in elderly myasthenia gravis patients.
- Published in:
- Muscle & Nerve, 2009, v. 40, n. 6, p. 952, doi. 10.1002/mus.21478
- By:
- Publication type:
- Article
Successful treatment of myasthenia gravis with tacrolimus.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis†.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2014, v. 45, n. 4, p. e76, doi. 10.1093/ejcts/ezt641
- By:
- Publication type:
- Article
Risk factors for tumor occurrence in patients with myasthenia gravis.
- Published in:
- Journal of Neurology, 2009, v. 256, n. 8, p. 1221, doi. 10.1007/s00415-009-5091-9
- By:
- Publication type:
- Article
Paraneoplastic diseases associated with thymoma.
- Published in:
- Journal of Neurology, 2007, v. 254, n. 6, p. 756, doi. 10.1007/s00415-006-0429-z
- By:
- Publication type:
- Article
Identification of Disease-Specific Autoantibodies in Seronegative Myasthenia Gravis.
- Published in:
- Annals of the New York Academy of Sciences, 2003, v. 998, n. 1, p. 356, doi. 10.1196/annals.1254.041
- By:
- Publication type:
- Article
Antibodies in Myasthenia Gravis and Related Disorders.
- Published in:
- Annals of the New York Academy of Sciences, 2003, v. 998, n. 1, p. 324, doi. 10.1196/annals.1254.036
- By:
- Publication type:
- Article
Congenital Myasthenic Syndrome (CMS) Type Ia: Clinical and Genetic Diversity<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1998, v. 841, n. 1, p. 157, doi. 10.1111/j.1749-6632.1998.tb10922.x
- By:
- Publication type:
- Article
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00613
- By:
- Publication type:
- Article
Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy.
- Published in:
- JAMA Neurology, 2017, v. 74, n. 4, p. 482, doi. 10.1001/jamaneurol.2016.5933
- By:
- Publication type:
- Article
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders.
- Published in:
- JAMA Neurology, 2016, v. 73, n. 11, p. 1342, doi. 10.1001/jamaneurol.2016.1637
- By:
- Publication type:
- Article
A Genome-Wide Association Study of Myasthenia Gravis.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 4, p. 396, doi. 10.1001/jamaneurol.2014.4103
- By:
- Publication type:
- Article
Clinical aspects of neuromuscular transmission disorders.
- Published in:
- Acta Neurologica Scandinavica: Supplementum, 2006, v. 113, p. 8, doi. 10.1111/j.1600-0404.2006.00606.x
- By:
- Publication type:
- Article
Human Leukocyte Antigen Class II associations in late‐onset Myasthenia Gravis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 3, p. 656, doi. 10.1002/acn3.51309
- By:
- Publication type:
- Article
Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy.
- Published in:
- Journal of Clinical Immunology, 2008, v. 28, n. 2, p. 194, doi. 10.1007/s10875-007-9147-2
- By:
- Publication type:
- Article
Circulating and thymic CD4<sup>+</sup> CD25<sup>+</sup> T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
- Published in:
- Immunology, 2005, v. 116, n. 1, p. 134, doi. 10.1111/j.1365-2567.2005.02220.x
- By:
- Publication type:
- Article
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
- Published in:
- Journal of Neurology, 2021, v. 268, n. 5, p. 1803, doi. 10.1007/s00415-020-10342-3
- By:
- Publication type:
- Article
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 5, p. 1115, doi. 10.1007/s00415-014-7532-3
- By:
- Publication type:
- Article
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 9, p. 2396, doi. 10.1007/s00415-013-6997-9
- By:
- Publication type:
- Article
Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Spontaneous recovery from anti-NMDAR encephalitis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
BAFF serum levels in myasthenia gravis: effects of therapy.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Imatinib mesylate in thymic epithelial malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 309, doi. 10.1007/s00280-011-1690-0
- By:
- Publication type:
- Article
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Controversies in Ocular Myasthenia Gravis.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.605902
- By:
- Publication type:
- Article
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00564
- By:
- Publication type:
- Article
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal".
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 4, p. 1162, doi. 10.1111/ene.15690
- By:
- Publication type:
- Article
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 1, p. 266, doi. 10.1111/ene.15565
- By:
- Publication type:
- Article
Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 8, p. 2505, doi. 10.1111/ene.15348
- By:
- Publication type:
- Article
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 2, p. 564, doi. 10.1111/ene.15161
- By:
- Publication type:
- Article
Response to: "MuSK‐positive myasthenia may be triggered not only by SARS‐CoV‐2".
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 10, p. e82, doi. 10.1111/ene.14827
- By:
- Publication type:
- Article
Myasthenia gravis associated with anti‐MuSK antibodies developed after SARS‐CoV‐2 infection.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 10, p. 3537, doi. 10.1111/ene.14721
- By:
- Publication type:
- Article
Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 5, p. 1020, doi. 10.1002/ana.27033
- By:
- Publication type:
- Article